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Glioma C62B cells, incubated for 18 h  with either  an 
unsaturated  (arachidonate or oleate) or  saturated (pal- 
mitate or  stearate) radioactive fatty acid, incorporated 
label  into most species of cellular glycerolipids. Treat- 
ment of prelabeled C62B cells with 1 mM acetylcholine 
(ACh) resulted in an accumulation of radioactive phos- 
phatidate  irrespective of which fatty acid was used as 
a label. However, only in cells prelabeled with  unsat- 
urated  fatty  acids  were  increases  in  radioactive  fatty 
acids observed. When exogenous radioactive arachi- 
donate  was added to C62B cells in  the presence of 1 
mM ACh, there was a rapid, selective, and  transiently 
enhanced incorporation of label  (several  times  the con- 
trol)  into phosphatidylinositol (PI).  The ACh-enhanced 
incorporation  into PI was not preceded by enhanced 
incorporation of label into sn- l,2-diacylglycerol or 
phosphatidate  but  was followed by an increased label- 
ing of polyphosphoinositides. Similarly,  incorporation 
of oleate into PI was enhanced by ACh. In  contrast, 
ACh did not enhance  the  incorporation of label  into 
any glycerolipids when saturated fatty acids were 
used. C62B cells, incubated  with [2-3H]inositol for 18 
h selectively incorporated label into phosphoinositides. 
Stimulation of [2-3H]inositol-labeled cells with 1 mM 
ACh in the presence of 25 mM LiCl resulted  in a rapid 
accumulation of radioactive inositol phosphates 
(mono-, bis-,  and  trisphosphates)  and glycerophospho- 
inositol. The accumulation of inositol trisphosphates 
preceded that of inositol monophosphate and glycero- 
phosphoinositol, while the accumulation of glycero- 
phosphoinositol paralleled the time required for the 
ACh-stimulated esterification of arachidonate. These 
results suggest that ACh stimulates activation of a 
phospholipase C in C62B cells and release of 1,4,5- 
inositol trisphosphate. There  is subsequent activation 
of phospholipase A2, which in turn  liberates arachido- 
nate  from PI. The  resulting lyso PI is  either  rapidly 
reesterified  with  unsaturated fatty acid to resynthesize 
PI,  or  further deacylated to yield glycerophosphoino- 
sitol. 
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A variety of stimuli  initiate the cleavage of arachidonate 
from glycerolipids; two primary mechanisms of liberation 
have been proposed. One pathway involves the activation of 
a calcium-regulated phospholipase A2 that  acts on membrane 
phospholipids to yield fatty acids and lysophospholipids (1- 
5). An alternative pathway involves the action of phospholi- 
pase C on phosphoinositides to yield inositol phosphates  and 
sn-1,Z-diacylglycerol. The sn-1,Z-diacylglycerol  may then be 
metabolized sequentially by di- and monoacyl  glycerol lipases 
to yield free fatty acids and glycerol  (6-8). 
Stimulated liberation of arachidonate  has also been shown 
to occur in neural systems (9-17). This is often thought of 
primarily in connection with neurons, although glial cells 
contribute substantially to the composition of the central 
nervous system (possibly outnumbering neurons 10 to 1; 18). 
Their  potential  contribution to neurotransmitter-stimulated 
liberation of arachidonate  has only recently been noted. Neu- 
rotransmitter-stimulated activation of phospholipase C has 
been demonstrated to occur in cultured glial cells (13,19)  and 
cells of glial origin (12,ZO). Moreover, it has been shown that 
certain  neurotransmitters  stimulate the liberation of arachi- 
donate from membrane phospholipids of glioma cells (10, 12) 
and cultured astroglia (13). (The term “liberation” is used 
here to indicate cleavage of the covalent bond so as to avoid 
confusion with “release” which often suggests extracellular 
accumulation). 
In  the present work we utilize cells of glial origin to examine 
in parallel the metabolic pathways responsible for acetylcho- 
line- (ACh)’ stimulated cleavage of arachidonate from mem- 
brane phospholipids and  the metabolism of inositol phospho- 
lipids. Our data suggest that although cholinergic stimulation 
of phosphodiesteratic degradation of phosphoinositides pre- 
cedes that of arachidonate liberation the two enzymes in- 
volved do not act sequentially on the same precursor sub- 
strate.  Furthermore,  there is an ACh-stimulated reacylation 
of liberated acyl groups. Thus,  the accumulation of free ara- 
chidonate is a transient event, compatible with responses 
characteristic of neural tissues. 
EXPERIMENTAL  PROCEDURES 
Materials 
from Gibco. [1-“CIArachidonate (58 mCi/mmol), [1-“Clstearate (60 
Basal medium Eagle’s (BME) and fetal calf serum were purchased 
‘The abbreviations used are: ACh, acetylcholine; BME, basal 
medium Eagle’s; Hepes, N-2-hydroxyethylpiperazine-N’-2-ethane- 
sulfonic acid; TLC,  thin-layer chromatography; HPLC, high pressure 
liquid chromatography; PI, phosphatidylinositol and corresponding 
1-alkenyl and 1-alkyl species; PE, phosphatidylethanolamine and 
corresponding 1-alkenyl and 1-alkyl species; PC, phosphatidylcholine 
and corresponding 1-alkenyl and 1-alkyl species; PS, phosphatidyl- 
serine and corresponding 1-alkenyl and 1-alkyl species. 
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mCi/mmol), [9,10-3H]palmitate (590 mCi/mmol), [1-"Cloleate (60 
mCi/mmol), rny0-[2-~H]inositol (14.2 Ci/mmol), [2-3H]inositol 1,4,5- 
trisphosphate, and [U-14C]inositol phosphatidylinositol were pur- 
chased from Amersham Corp. [Methyl-3H]choline (80.0 Ci/mmol) 
and [l-3H]ethanolamine (8.7 Ci/mmol) were purchased from Du 
Pont-New  England Nuclear and Amersham Corp., respectively. 
Acetylcholine, phospholipid standards, and phospholipase Az (from 
nuja nuja venom) were obtained from Sigma. LK6D thin-layer  chro- 
matography (TLC)  plates were purchased from Whatman. All other 
materials were reagent grade. 
Methods 
Cell Cdture Conditions-The culture medium for C62B cells con- 
sisted of BME supplemented with 5% (vol/vol) fetal calf serum, 1 
mM glucose, 2 mM L-glutamine, 50 units/ml of penicillin, and 50  pg/ 
ml of streptomycin. Cells were  grown in 15 ml  of this medium in 75- 
cm2 Corning culture flasks in  a humidified environment of 5% COz 
and 95% air  at 37  "C. The medium  was changed every 3 days. 
Prelubeling of CeUs with  Radioactive Fatty Acids, and my0-[2-~H] 
Inositol, [methyl-3H]Choline, and [I -3H]Ethanolamine-Confluent 
cell cultures were harvested and seeded into sterile glass scintillation 
vials as previously described (12). The cultures were incubated for 24 
h prior to addition of radioactive fatty acids or inositol. The culture 
medium was removed by aspiration, and  the cells were labeled by 
incubation for 18 h  in 0.75 ml of fresh culture medium containing 
either radioactive arachidonate, oleate, stearate (0.25 pCi/vial), or 
palmitate (2.0 pCi/vial). This protocol resulted in 90.5 f 2.6,  82.2 -t 
1.1, 74.3 f 6.3, and 41.3 f 1.7 (%X f S.E., n = 6), respectively, of 
the radioactivity incorporated in the cellular lipid pool (not removed 
by rinsing the cultures). In instances where metabolism of phospho- 
inositides, phosphatidylcholine, or phosphatidylethanolamine were to 
be examined, cultures were incubated for 18 h with culture medium 
containing [2-3H]myo-inositol (25 pCi/vial), [methyl-3H]choline (3 
pCi/vial), or [l-3H]ethanolamine  (3 &i/vial), respectively. 
Assay for Accumulation of Fatty Acids, Inositol Phosphates, and 
Glycerophosphoinositol-Following labeling of cultures, the medium 
containing unincorporated precursor was  removed. The cultures were 
then rinsed three times with BME, the medium replaced with fresh 
BME, pH 7.2, containing 30 mM Hepes, and  the culture vials placed 
in  a 37 "C water bath. In the inositol-labeling experiments, the final 
wash and incubation was with Hanks' balanced salt solution buffered 
at  pH 7.2 with 15 mM Hepes. Lithium chloride (25 mM) was added 
to inhibit inositol phosphate phosphatase. 
Solutions of ACh and eserine were made as previously reported 
(12). The cultures were incubated at 37 "C for the times indicated. 
The reactions were stopped and  the extracts prepared by addition of 
2.8 ml of either chloroform/methanol (1:2), chloroform/methanol/ 
hydrochloric acid (v/v/v, 100:2002), or  butanol (21) as noted in the 
text. 
Assay for Incorporation (Esterification) of Fatty Acids-Cell cul- 
tures were prepared as above with the omission of radioactive fatty 
acid in the culture medium. Following replacement of the culture 
medium with buffered BME, assay for incorporation of radioactive 
fatty acid was initiated by addition of  4-5 nmol of radioactive fatty 
acid per culture  in the presence or absence of  ACh. The incorporation 
of fatty acid into glycerolipids was terminated as above. 
Lipid Analysis-Cell extracts were transferred to centrifuge tubes 
and 0.9 ml of chloroform and 0.9 ml of water were added. Following 
agitation on a Vortex shaker, the phases were separated by centrif- 
ugation and  the organic phase removed and evaporated to dryness 
under a stream of nitrogen. The resulting sample residues were 
dissolved in 50 ul  of chloroform/methanol (1:l) and portions applied 
to  TLC plates. 
Triglycerides (RF = 0.85), diglycerides (RF = 0.73), and  fatty acids 
(R,  = 0.55) were separated from phospholipids (origin) on LK6D 
TLC plates using a  solvent consisting of the upper phase obtained 
after phase separation of a mixture of ethyl acetate/isooctane/water 
(v/v/v, 93:47120). Use of this system in combination with nonacidic 
extraction (see above) prevented acid hydrolysis of  plasmalogens. 
Phosphatidate was separated from other lipids in  a solvent consisting 
of the upper phase of a mixture of ethyl acetate/isooctane/acetic 
acid/water (v/v/v/v, 93:47:20100) as previously reported (12). 
Separation of phospholipids was performed on Silica Gel LK6D 
TLC plates developed in chloroform/ethanol/water/triethylamine (v/ 
v/v/v, 3034835) (22). In  this system the major diacyl-phospholipids 
(and the corresponding comigrating 1-alkenyl and 1-alkyl species) 
dylserine (PS), 0.17; phosphatidylinositol (PI), 0.24; phosphatidate, 
had RF values as follows: phosphatidylcholine (PC), 0.12; phosphati- 
0.30; phosphatidylethanolamine (PE), 0.36. Polyphosphoinositides 
were resolved using acid extracts of cell lipids and  TLC on oxylate- 
coated LK6D TLC plates  in  a system of chloroform/methanol; 4 N 
ammonium hydroxide (v/v/v, 45:35:10). Plasmalogen composition of 
glycerophospholipids was determined by two-dimensional TLC (23). 
The protocol involves separation of phospholipids in the first dimen- 
sion  with chloroform/methanol/ammonium hydroxide  (v/v/v, 
65254), hydrolysis of the acid labile vinyl ether bond of plasmalogen 
by exposure to concentrated hydrochloric acid vapor, and separation 
of lysophospholipids generated from phospholipids in the second 
dimension in chloroform/methanol/acetone/acetic acid/water (v/v/ 
v/v/v, 75:15:3015:7.5). In experiments where glycerolipids were to be 
examined without hydrolysis of plasmalogens, either an aqueous 
butanol or neutral chloroform/methanol extraction was used (21). 
[methyl-3H]Choline-labeled lipids and [l-3H]ethanolamine-labeled 
lipids were  resolved on LK6D TLC plates  in  a system of chloroform/ 
methanol/water (v/v/v, 65356) or chloroform/methanol/water (v/ 
v/v, 65:254), respectively. Relative mass distribution of phospholipids 
was determined by spraying TLC plates with 50% sulfuric acid in 
ethanol and heating at 180 'C to visualize lipids by charring. Quan- 
titation was performed using soft laser densitometry (Zenith SL-504- 
XL), and  data are  presented as a percentage of the  total phospholipid 
(this was determined to be 22 f 2.7  pg  of phospholipid/culture (mean 
f S.E.,  n = 4)). 
The locations of labeled species separated by TLC were visualized 
by autoradiography using Kodak XAR film. In  the case of tritium- 
labeled samples, TLC plates were sprayed with EN3HANCE (Du 
Pont) prior to autoradiography. Glycerolipid identity was determined 
by comparison with standards visualized by exposure to iodine. Quan- 
tification of radioactivity was determined by scraping regions of the 
TLC plates into scintillation vials followed by liquid scintillation 
spectrometry. 
Hydrolysis of Phospholipids by Phospholipase A*-Phospholipase 
Az hydrolysis of phospholipids was as previously described (12). 
Hydrolysis of phospholipids was quantitated by isolation of esterified 
radioactive fatty acid by TLC and  determination of radioactivity as 
noted above. 
Separation of Inositol Phosphates and of Glycerophosphoinositol- 
The aqueous phase of cell extracts prepared from inositol-labeled 
cells were dried under nitrogen to 1 ml then diluted to 20 ml with 
water. The samples were then either subjected to Dowex AG1-X8 
anion exchange chromatography (4) or HPLC analysis using a mod- 
ification of the method of Irvine and co-workers (24). The modifica- 
tion  entailed the use of a microprocessor-controlledprepump gradient 
mixer with a 3-step linear gradient of water and 1 M ammonium 
formate buffered to pH 3.7 with phosphoric acid (100% water, 0-20 
min; 100% water to 45% ammonium formate, 20-40 min; and 45% 
ammonium formate to 85% ammonium formate, 40-70 min). The 
samples were chromatographed at a flow rate of 1 ml/min, and 70 
fractions (1 ml each) were collected. The radioactivity present in the 
eluent was quantitated by liquid scintillation spectrometry. Inositol 
phosphates were identified by coelution with standards. Glycerophos- 
phoinositol was prepared by methylamine hydrolysis of [3H]inositol- 
labeled cell lipid extracts (25). Cyclic inositol monophosphate was 
prepared by cyclization of [U-"Clinositol monophosphate (26). 
RESULTS 
Distribution of Label  From  Incorporated  Fatty  Acids 
Distribution among Glycerolipid Species"C62B glioma 
cells  were  incubated for 18 h in the presence of the various 
fatty  acids, and the  incorporation of radioactivity  into glyc- 
erophospholipids  was  determined  (Table I). This  distribution 
did not  correspond  to  the  glycerophospholipid  relative mass 
composition of the cells. Label from [l-14C]arachidonate or 
from  [1-l4C]stearate  was 3- t o  4-fold  enriched  in PI relative 
to the percentage PI composition of the cells. In contrast, 
oleate and palmitate  preferentially  labeled PC. 
Plasmalogen  Composition of C62B Cells-The incorporation 
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TABLE I
Distribution of radioactive free  fatty acids incorporated into glycerolipids 
Each  value is the mean of six determinations. 
Phospholipid 
commsition" Arachidonate Oleate Stearate 
Palmitate 
PC 
cpm X 10-2/culture + S.E. 
56.5 f 4.4 1180 f 40 (36.5)b 2463 f 26 (74.6) 1126 f 49 (48.4) 2814 f 39 (72.6) 




3.5 f 1.9 598 f 26 (18.4) 100 f 3.8 (3.0) 373 f 32 (16.0) 193 f 7.8 (5.0) 
5.2 -+ 1.6 155 f 6.1 (4.8) 128 f 13 (3.9) 273 f 31 (11.7) 110 f 3.1  (2.8) 
4 . 0  32 f 1.3 (1.0) 28 f 1.7 (0.7) 30 k 1.1 (1.3) 28 f 1.9 (0.7) 
Neutral  liDids 279 f 27 (8.6) 222 f 25 (6.7) 151 f 16 (6.5) 484 f 7.5 (12.5) 
Values  are the mean of four  determinations  and  are  presented as the percentage of total  phospholipid. 
Numbers in parenthesis  represent  the percentage of radioactivity  incorporated into the individual  glycerolipids. 
PA, phosphatidate. 
of labeled fatty acid into plasmalogens was determined in  a 
separate series of experiments. Following 18 h of incubation 
with radioactive arachidonate, much of the label which co- 
migrated with PC and  PE was present  as plasmalogen (19 r 
3%  and 71 f 2%,  n = 4, respectively). Radioactivity in lipids 
isolated from stearate-labeled cells comigrating with PC  and 
PE also included plasmalogens (5 f 0.3% and 26 f 3%, n = 
4, respectively). This was determined by  weak acid hydrolysis 
of lipid classes separated by TLC  after  extraction of phospho- 
lipids by nonacidic extraction procedures (weak acid causes 
cleavage of the vinyl ether bond of plasmalogens to release 
the aldehyde). Radioactivity of arachidonate  present  in plas- 
malogens was primarily in the lysophospholipid generated by 
such  treatment, whereas radioactivity incorporated from 
stearate was released from the phospholipid. Interestingly, 
when cells were labeled with radioactive arachidonate or 
stearate, a significant amount of radioactivity comigrating 
with PI was present as plasmalogen (18 f 6%  and  6 f 2%,  n 
= 4, respectively). 
The presence of inositol plasmalogen was further  substan- 
tiated using butanol-extracted [2-3H]inositol-labeled cells, in- 
dicating that 14 f 2% (n = 5) of the [3H]inositol-labeled PI 
was present  as plasmalogen. The extreme lability of plasmal- 
ogens upon exposure to acid dictates that caution be used in 
interpreting data concerning the lysophospholipid content of 
cells where acidic lipid extraction procedures or acidic solvent 
systems for separation of phospholipid classes have been used. 
Such treatment could substantially elevate "basal" levels of 
lysophospholipids and mask potential agonist-induced 
changes in cellular lysophospholipid content (see lyso PI 
determination below). 
Distribution of Label with Regard to Positional Specificity- 
The distribution of radioactive fatty acids esterified at  the  sn- 
2 position of the  total glycerolipids was determined by their 
susceptibility to release by phospholipase A,. This  treatment 
substantially decreased the radioactivity of arachidonate  pres- 
ent in  glycerolipids leaving only 13 f 3% (n = 3) incorporated 
(of the remaining covalently linked radioactive arachidonate, 
41% was present as neutral lipids and not susceptible to 
phospholipase A2-mediated hydrolysis). In  contrast, 75 f 4% 
(n = 3) of the radioactivity of stearate remained incorporated 
after phospholipase A, treatment, suggestive of a primary 
localization in  the  sn-1 position. The radioactivity incorpo- 
rated from oleate and palmitate remaining as glycerolipid 
following phospholipase A2 treatment (28 f 4% and 53 f 8%, 
TABLE I1 
Acetylcholine-stirnuluted accumulation of radioactive free  fatty acids 
and radioactive phosphutidates 
Free fatty acid  and  phosphatidate  accumulations were determined 
at 90 s and 2 min post ACh treatment, respectively. Each value 
represents the mean of two experiments performed in triplicate. 
Asterisks (*) indicate  statistically  significant  differences ( p  < 0.01) 
from untreated  control. 






Palmitate - + 
Stearate - + 
cpm cultur 
1178 f 119 
3746 f 278* 
1048 f 78 
2487 f 212' 
4199 f 208 
4466 f 309 
3442 f 246 
4219 f 431 
'e k S.E. 
929 f 88 
3161 f 186* 
1124 f 38 
2882 f 139* 
1310 f 106 
2940 k 201' 
1021 f 77 
2662 & 387* 
respectively, n = 3) was intermediate to  that for  arachidonate 
and  stearate. 
Fatty Acid Liberation from Prelubeled Cells 
Acetylcholine-stimulated Liberation of Fatty Acid from Pre- 
labeled  Cells-When  C62B cells were prelabeled with any of 
the  fatty acids examined, treatment with 1 mM ACh increased 
the accumulation of radioactive phosphatidate  (Table 11) (a 
concentration previously shown to give maximal response, 
Ref. 12). Arachidonyl-labeled phosphatidate showed the 
greatest (3.4-fold) elevation following a 2-min stimulation 
with ACh (time of maximal stimulated accumulation). Stim- 
ulated accumulation of phosphatidate labeled with the other 
fatty acids ranged from 2.2 to 2.6 times control values. The 
accumulation of radioactive phosphatidate, irrespective of the 
fatty acid used, suggest that the phospholipase C activity 
stimulated by  ACh  hydrolyzes phosphoinositides without re- 
gard for fatty acid composition. 
When the ACh-stimulated accumulation of radioactive 
fatty acids was examined, only in  the case of the unsaturated 
fatty acids, arachidonate  and oleate, were there  statistically 
significant and  substantial increases (3.2- and 2.3-fold of the 
respective control levels, Table 11). 
Esterification of Fatty Acids into Glycerolipids 
Acetylcholine-stirnuluted Esterification of Arachidonate into 
Glycerolipids-We had previously demonstrated that, even in 
8080 Acetylcholine-stimulated Glial Phospholipid Metabolism 
FIG. 1. Time course of [l-"C]ar- 
achidonate incorporation into gly- 
cerolipids. Cultures of C62B cells were 
incubated for the times indicated with 
exogenous [I-"Clarachidonate in the 
presence (0) or absence (0) of 1 mM 
ACh.  Each  data point is  the mean & S.E. 
of 3-6 experiments performed in dupli- 
cate. Additional abbreviations used in 
this figure are: DG, diacylglycerol; PA, 
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the presence of continuous cholinergic stimulation, the ele- 
vated levels of unesterified radioactive arachidonate  returned 
to control levels within 5 min (12). Our observations suggested 
the hypothesis that  the rapid return  to basal levels resulted 
from an ACh-stimulated re-esterification of the arachidonate 
(or metabolites of arachidonate)  into cellular glycerolipids. 
The above hypothesis was tested by examining the effect 
of  ACh on the esterification of exogenous [l-14C]arachidonate 
into glycerolipids (Fig. 1). In the absence of ACh,  following a 
short delay period, the added [l-14C]arachidonate was rapidly 
incorporated into  neutral lipids and phospholipids. Phospha- 
tidate and sn-1,2-diacylglycerol labeled most rapidly, with 
transient accumulations which peaked by 2 min. After initial 
delays of 1-2 min PC, PE, PI, and triacylglycerol showed 
increased incorporation of radioactivity that continued for 
over 30 min. The largest incorporation of [l-14C]arachidonate 
during the 30-min labeling period was shown by PC and 
triacylglycerol, accounting for over 74% of the  total radioac- 
tivity incorporated. Little label was incorporated into PS 
during  this time (data  not shown). 
When ACh (1 mM) was added simultaneously with the  [l- 
14C]arachidonate, the  total incorporation of radioactivity into 
phospholipids was increased by 48 f 6% at 2 min (sum of 
data from different panels, Fig. 1). This was  largely accounted 
for by a %fold increased incorporation into phosphoinositides 
(Fig. 1). ACh had  little effect on the incorporation of arachi- 
donate  into  PC, PE, sn-1,2-diacylglycerol, or phosphatidate. 
Incorporation  into triacylglycerol was decreased by half at 2 
min (Fig. 1). This may reflect increased competition for acyl- 
CoA, diversion to PI synthesis rather than triacylglycerol 
synthesis. The ACh-enhanced esterification of exogenous ar- 
achidonate  into PI closely parallels the time course for liber- 
ation  and re-esterification of endogenous [l-14C]arachidonate 
previously reported (12). 
Because the enhanced incorporation of arachidonate  into 
phospholipids was selective for PI, we examined the incorpo- 
ration of exogenous radioactive arachidonate  into polyphos- 
phoinositides (Fig. 2). The data indicate that the ACh-en- 
hanced incorporation of [ 1-l4C]arachidonate  into polyphos- 
phoinositides followed the appearance of label in PI. This 
temporal sequence is compatible with sequential phosphoryl- 
ation of the radioactive arachidonyl-PI to form phosphatidyl- 
inositol mono- and bisphosphates. 
Acetylcholine-enhanced Esterification of Other Fatty Acids 
into Glycerolipids-In addition to  the time course studies with 
arachidonate (Fig. l),  the effects of ACh on the esterification 
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FIG. 2. Time course of acetylcholine-stimulated incorpora- 
tion of [1-"Clarachidonate into phosphoinositides. Cultures of 
C62B cells were treated as  in Fig. 1 and phosphoinositides separated 
by TLC. Incorporation of radioactivity into PI (O), phosphatidyli- 
nositol-monophosphate (PIP; H), and phosphatidylinositol-bisphos- 
phate (PIP,; A) was determined. Panel A, incorporation of [l-"C] 
arachidonate under control conditions. Each value is  the mean & S.E. 
Panel B ,  the data for ACh-stimulated (1 mM ACh) cultures are plotted 
cpm/culture from two experiments performed in triplicate (n  = 6). 
as a percentage of  label  incorporated into control cultures incubated 
for the equivalent times in the absence of ACh. Each value is the 
average of two experiments, each performed in triplicate. The S.E. 
for the stimulated cultures were less than 15% of the corresponding 
means and similar to those of the control cultures. 
time  point (10 min). The only statistically significant differ- 
ence (p  < 0.01, n = 6) was the enhanced incorporation of 
radioactive oleate into  a single phospholipid, PI. ACh did not 
increase the incorporation of the  saturated  fatty acids (stea- 
rate or palmitate)  into  any glycerolipids. These  results suggest 
that  there is a selective effect of ACh on the incorporation of 
unsaturated  fatty acids, which are preferentially esterified at 
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the  sn-2 position of phospholipids. Moreover, the increased 
esterification of unsaturated  fatty acids is specific for  PI. 
Phosphoimsitide Metabolism Stimulated by Acetylcholine 
ACh-stimulated Increase in Lyso-PI-The selective en- 
hanced incorporation of exogenous unsaturated fatty acids 
into PI and  the lack of ACh-enhanced esterification of exog- 
enous fatty acids into 1,2-diacylglycerol or phosphatidic acid 
suggested to us that  the increased incorporation occurred via 
the esterification of a lyso-PI. Therefore, we attempted to 
determine if lyso-PI was formed upon stimulation of cells 
with ACh.  C62B  cells, prelabeled for 18 h with [2-3H]inositol, 
were stimulated for 90 s with ACh or the calcium ionophore 
A23187 and  the lipid extracts analyzed (Table 111). We de- 
tected small but significant ( p  < 0.01) accumulations of 
radioactive lyso-PI for both ACh and A23187 treatment (30 
and 70% above control, respectively). The accumulation in 
response to ACh  was transient;  after  a 5-min stimulation with 
ACh, lyso-PI  returned to basal levels. In  contrast,  after treat- 
ment with A23187 for 5 min radioactive lyso-PI levels re- 
mained elevated. The ACh-stimulated increase in lyso-PI was 
not  statistically significant when acidic extraction procedures 
were used presumably because of the elevated basal lyso-PI 
levels resulting from plasmalogen degradation (see data in 
plasmalogen content section). The effects of ACh and iono- 
phore on the accumulation of lyso-PE  and lyso-PC were also 
examined (Table 111). No statistically significant increases 
were observed with 90-s exposure to either  agent, however, 
A23187 did increase accumulation of lyso-PE  after 5 min. 
Determination of ACh-stimulated Accumulation of Inositol 
Phosphates  and Glycerophosphoinositol-ACh stimulated a 
rapid (within 5 s) and transient (peaking within 1-5 min) 
accumulation of inositol trisphosphates (Fig. 3). The early 
accumulation of inositol trisphosphates was followed by 
slower accumulations of inositol bisphosphate and glycero- 
phosphoinositol. The accumulation of inositol  monophos- 
phate occurred more slowly and was accompanied by a  return 
to basal levels of inositol bis- and trisphosphates. The accu- 
mulation of glycerophosphoinositol remained elevated and 
paralleled in  time the ACh-enhanced esterification of arachi- 
donate (cf.  Fig. 1). 
Analysis by HPLC of the water-soluble components from 
TABLE I11 
Acetylcholine- and ionophore A23187-stimulated accumulation of 
radioactive lysophospholipids 
choline “Methods” were treated with acetylcholine or A23187 for the 
Cultures  preincubated with radioactive inositol, ethanolamine,  or 
times indicated. The lipids were extracted, the lipid classes separated, 
and  the radioactivity present  in the lysophospholipids determined. 
Each value is the mean from duplicate determinations from 6-9 
cultures. Asterisk (*) indicates statistically significant difference ( p  
< 0.01) from equivalent time control. Total radioactivity (cpm & 
S.E.) a t  the 90-s time  point  present as  PI + lyso-PI, PE + lyso-PE, 
and PC + lyso-PC was 247,377 f 12,067, 366,262 f 15,921, and 
471,592 f 17,077 and did not vary significantly for the time or 
treatment variables noted. 
Treatment Lyso-PI LYSO-PE Lyao-PC 
cpmlcrrlture + S.E. 
Control 90 s 8,620 f 372 19,589 f 1,213 5,462 f 345 
ACh (1 mM) 90 s 11,470: f 555 20,248 f 860 5,889 f 517 
A23187 (5 pM) 14,614’ & 1,051 21,429 f 1,025 6,664 f 681 
Control 5 min 
ACh (1 mM) 
9,360 f 383  18,977 f 904  6,508 f 623 
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FIG. 3. Time course of Ach-stimulated accumulation of ino- 
sitol phosphates and glycerophosphoinositol. Cultures of C62B 
cells labeled with [2-3H]inositol were incubated in  the presence (solid 
line) or absence (broken line) of 1 m~ ACh for the times indicated. 
Inositol trisphosphate (IP3), inositol bisphosphate UP2), inositol mon- 
ophosphate (ZP), and glycerophosphoinositol (GPZ) present in the 
aqueous fraction of cell extracts were separated by Dowex anion 
exchange chromatography “Methods”. The data are presented as 
radioactivity/culture present in the relevant fraction. Each value is 
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FIG. 4. HPLC analysis of inositol phosphates accumulating 
after ACh stimulation (1 mM ACh) of C62B cells. Aqueous 
phase of C62B cell extracts prepared as in Fig. 3 were subjected to 
HPLC separation “Methods”. Data from a representative experiment 
are shown for control (no ACh), 5-9 ACh stimulation, 30-s ACh 
stimulation, and 30-min ACh stimulation. In addition to  the abbre- 
viations used in Fig. 3: 1,4,5-zp3, inositol 1,4,5-trisphosphate, 1,3,4- 
ZP,, inositol 1,3,4-trisphosphate. 
ACh-treated cultures allowed us to examine independently 
the accumulation of inositol 1,4,5- and 1,3,4-trisphosphates 
(Fig. 4) and indicated that ACh caused a rapid accumulation 
of inositol 1,4,5-trisphosphate (this compound is known to 
mobilize intracellular calcium, Ref. 27). 
Treatment of C62B cells with ionophore A23187 likewise 
resulted in increased glycerophosphoinositol accumulation 
(Fig. 5) but unlike ACh, failed to elevate inositol phosphates. 
This uncoupling of the accumulation of these products by the 
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FIG. 5. Effect of ACh, and of the ionophore A23187, on the 
accumulation of glycerophosphoinositol and inositol phos- 
phates. Cultures of C62B cells prelabeled with [2-3H]inositol were 
treated with 1 mM ACh or 5 PM A23187 for the times indicated. 
Glycerophosphoinositol was separated from pooled inositol phos- 
phates (includes inositol mono-, bis-, and trisphosphates).  Each value 
(presented as radioactivity/culture) is the mean f S.E. of two exper- 
iments performed in  triplicate. 
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FIG. 6. Schematic representation of ACh-stimulated phos- 
phoinositide metabolism. Bold arrows indicate major metabolic 
pathways. ACh receptor occupation activates phospholipase C with 
production of Ca2+ mobilizing inositol 1,4,5-trisphosphate. Elevation 
of cellular CaZ+  activates phospholipase A2 which selectively liberates 
unsaturated  fatty acids from PI generating  LPI. LPI is either  further 
deacylated to glycerophosphoinositol or subsequently reacylated with 
unsaturated fatty acids (arachidonate or metabolites of arachidonate) 
to yield PI. The  PI may then be successively phosphorylated to yield 
the polyphosphoinositides or may be reutilized in the release of 
arachidonate. Abbreviations used in addition to those in previous 
figures are: AA, arachidonate; SA, stearate, CDP-DG, CDP-diacyl- 
glycerol; LPZ, lysophosphatidylinositol; P h e  AP, phospholipase AP; 
P h e  C, phospholipase C; DG, diacylglycerol; I ,  inositol. 
ionophore indicates that glycerophosphoinositol production 
is independent of phospholipase C activation and supports 
the involvement of calcium-regulated phospholipase A, activ- 
ity. 
DISCUSSION 
Pathway  for Arachidonate Release and Reacylation-ACh 
stimulates the liberation of arachidonate  and the subsequent 
reesterification of arachidonate  (or metabolites of arachido- 
nate) in C62B cells. We suggest this involves the pathway 
depicted in Fig.  6. In  this scheme ACh occupation of a mus- 
carinic receptor on C62B cells results in activation of phos- 
pholipase C with subsequent hydrolysis of phosphoinositides 
and production of inositol phosphates (including the calcium 
mobilizing inositol 1,4,5-trisphosphate) and 1,2-diacylglyc- 
erol. The 1,2-diacylglycerol formed is rapidly phosphorylated 
to form phosphatidate  and utilized in  the resynthesis of PI. 
The accumulation of inositol 1,4,5-trisphosphate (27), the 
degradation of polyphosphoinositides (28), or the formation 
of other  products of phosphoinositide metabolism (29,  30) in 
turn may elevate intracellular calcium, possibly resulting in 
the activation of the calcium regulated phospholipase A2. 
Phospholipase A, then selectively liberates unsaturated  fatty 
acids present in the sn-2 position of PI  to yield primarily 
arachidonate  and lyso-PI. The lyso-PI formed is either rapidly 
reacylated with unsaturated fatty acids (or metabolites of 
unsaturated fatty acids) or is further deacylated to yield 
glycerophosphoinositol. Because we detect little accumulation 
of stearate under our experimental conditions, it is suggested 
that  the re-esterification pathway predominates in C62B cells 
(there may  be some stimulation of stearate release, but it is 
low compared to arachidonate, Table 11). 
The failure to observe ACh-enhanced esterification of ara- 
chidonate into sn-l,2-diacylglycerol or  phosphatidate, coupled 
with the selectivity for esterification into PI, suggests that 
the increased incorporation of radioactive arachidonate  into 
PI is not the result of de mu0 phospholipid synthesis, but 
instead occurs via a  stimulation of a deacylation-reacylation 
pathway. The selectivity for unsaturated fatty acid release 
and esterification further support our hypothesis that the 
enhanced incorporation is not due to phospholipase C-de- 
pendent catabolism of PI  and subsequent release of both the 
sn-1 and  sn-2  fatty acids from diacylglycerol. Were this  later 
pathway involved we would expect saturated  and  unsaturated 
fatty acids to demonstrate nearly equivalent release and es- 
terification. 
The model presented emphasizes that  the accumulation of 
liberated arachidonate within the cells is dependent upon the 
relative rates of deacylation and reacylation (31), both of 
which appear stimulated in C62B cells. This scheme also 
emphasizes that in cells of glial origin (as has been shown in 
some non-neural systems (32)), the liberation of arachidonate 
by phospholipase A, and phosphodiesteratic degradation of 
phosphoinositides can  share  a common precursor pool, PI. In 
other neural systems where agonist-stimulated phosphoino- 
sitide metabolism has been studied, it has been reported that 
tetraenoic species of phosphoinositides are conserved (33-35) 
and that elevation of lyso-PI is not detected (34,36). Although 
these observations were interpreted differently by the authors, 
the  data  are not  inconsistent with a  transient liberation of 
arachidonate from PI via a phospholipase A2 with subsequent 
reacylation of the lyso-PI formed. In C62B cells, and possibly 
in other neural systems, the accumulation of glycerophos- 
phoinositol is stable under conditions where lyso-PI may  be 
rapidly further metabolized (reacylated or  further deacylated). 
Glycerophosphoinositol may thus provide a more sensitive 
and readily monitored indicator of fatty acid liberation from 
phosphoinositides than does lyso-PI. 
Possible Significance of the  Transient Liberation of Arachi- 
donate-The release and accumulation of arachidonate in 
response to physiologically significant stimuli has been well 
characterized in many systems (14, 37-40). The transient 
nature of the accumulation of arachidonate following expo- 
sure to ACh noted in  the present study (it is rapidly reversed 
by re-esterification) might be of particular relevance with 
regard to  the  short  term responses characterized by neural 
systems. It has been shown that arachidonate (41, 42) and 
Acetylcholine-stirnuluted Glial Phospholipid Metabolism 8083 
arachidonate metabolites (43) can  activate  protein kinase C 
( Ca2+/phospholipid-dependent enzyme) independent of phos- 
pholipid requirements. It is also noteworthy that arachidonate 
(44)  and metabolites of arachidonate (45) elevate intracellular 
calcium, in some instances  this effect may be additive with 
the elevation caused by inositol 1,4,5-trisphosphate (44). 
Thus, free arachidonate may contribute to  the regulation of 
calcium-dependent and phosphorylation-dependent events 
within the cell. Finally, as ACh stimulates  a  transient accu- 
mulation of a lipoxygenase metabolite (12), the lipoxygenase 
metabolite may also be rapidly esterified (46), and may serve 
to modulate membrane function as has been shown with 
alteration of phospholipid fatty acid composition (47,48). 
Our supposition that these findings obtained with a glial 
cell line are of physiological relevance (glial-neuronal inter- 
actions in uiuo) remains to be tested. Observations with as- 
troglia in culture indicate that they, like C62B  cells, respond 
to putative neurotransmitter receptor agonists with arachi- 
donate liberation (13) and phosphoinositide metabolism (13, 
19). Our results  are compatible with a growing  body of liter- 
ature, which suggests that glial cells may contribute  substan- 
tially to neurotransmitter-stimulated phospholipid metabo- 
lism in central nervous system tissues. 
final preparation of this manuscript. 
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